Therapeutic Potential of the miRNA-ATM Axis in the Management of Tumor Radioresistance

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• The ataxia-telangiectasia mutated (ATM) protein kinase is a central regulator of the DNA damage response (DDR), particularly following DNA double-strand breaks.
• ATM influences the DDR by modulating microRNA (miRNA) expression through various pathways.
• Conversely, specific miRNAs directly target the 3'-untranslated region of ATM mRNA, establishing a feedback regulatory loop.

Purpose of the Study:

• To review the complex interplay between miRNAs and ATM in the context of DNA damage.
• To elucidate the molecular mechanisms governing miRNA-ATM interactions.
• To discuss the therapeutic applications of miRNAs targeting ATM, including strategies for delivery in challenging environments like hypoxic tumors.

Main Methods:

• Literature review and synthesis of existing research on miRNA-ATM interactions.
• Analysis of molecular mechanisms involved in miRNA-mediated regulation of ATM.
• Examination of studies on therapeutic delivery of miRNAs, with a focus on hypoxic tumor microenvironments.

Main Results:

• ATM and miRNAs engage in a bidirectional regulatory relationship crucial for DNA damage signaling.
• Understanding these interactions provides insights into potential therapeutic targets for diseases involving DNA repair deficiencies.
• miRNA-based therapies show promise, with ongoing research into effective delivery systems for various tumor conditions.

Conclusions:

• The intricate crosstalk between ATM and miRNAs is fundamental to cellular responses to DNA damage.
• Targeting this interaction offers novel therapeutic avenues for cancer and other diseases.
• Further research into miRNA delivery, especially in hypoxic tumor microenvironments, is essential for clinical translation.